OR13J1

Across TCGA pan-cancer cohorts, OR13J1 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated OR13J1 data layer compared with 1 for mutation status.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher OR13J1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR13J1 expression acts as an unfavorable survival marker, although some lineages such as CESC and ESCA show a favorable association.

DLBC, KIRP, and CESC are the cancer types where OR13J1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	OS	Quartile	All	0.207	1.000	<.001	51	view →
KIRP	DFS	Quartile	All	0.815	0.951	.003	31	view →
CESC	DFS	Median	IV	0.599	0.090	.002	30	view →
THYM	OS	Quartile	All	0.754	1.000	.003	27	view →
BLCA	OS	Median	IV	0.223	0.563	.006	24	view →
UCEC	OS	Quartile	II,III,IV	0.281	0.791	.003	24	view →
ESCA	OS	Median	III,IV	0.731	0.437	.001	21	view →
PRAD	DFS	Median	All	0.822	0.942	<.001	20	view →
THCA	DFS	Quartile	II,III,IV	0.694	0.916	.002	18	view →
LUSC	DFS	Quartile	All	0.553	0.679	.012	14	view →
ACC	DFS	Tertile	II,III,IV	0.256	0.656	.017	11	view →
SKCM	DFS	Tertile	II,III,IV	0.437	0.215	.011	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

OR13J1–DLBC (OS)

Open the DLBC breakdown →